Increased expression of cyclin E is associated with an increased resistance to doxorubicin in rat fibroblasts

British Journal of Cancer

Volumn 88, Issue 12, 2003, Pages 1956-1962

  Sgambato, A ^a   Camerini, A ^a   Pani, G ^a   Cangiano, R ^a   Faraglia, B ^a   Bianchino, G ^a   De Bari, B ^a   Galeotti, T ^a   Cittadini, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Cyclin E; Doxorubicin; Drug resistance; Rat fibroblasts

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; CYCLIN DEPENDENT KINASE 2; CYCLIN E; DNA; DOXORUBICIN; ETOPOSIDE; MANGANESE SUPEROXIDE DISMUTASE; METHOTREXATE; PACLITAXEL; PARAQUAT; REACTIVE OXYGEN METABOLITE; RETROVIRUS VECTOR; VINCRISTINE;

ANIMAL CELL; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG RESISTANCE; DRUG SENSITIVITY; ENZYME ACTIVITY; FIBROBLAST; NONHUMAN; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELLS, CULTURED; CYCLIN E; DOXORUBICIN; DRUG RESISTANCE; FIBROBLASTS; RATS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 0038235991     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600970     Document Type: Article

References (43)

1. Beauchamp C, Fridovich I (1971) Superoxide dismutase: improved assays and one assay applicable to acrylamide gels. Anal Biochem 44: 276-287
2. Bortner DM, Rosenberg MP (1997) Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol Cell Biol 17: 453-459
3. Bus JS, Aust DD, Gibson JE (1974) Superoxide- and singlet oxygen-catalyzed lipid peroxidation as a possible mechanism for paraquat (methyl viologen) toxicity. Biochem Biophys Res Commun 58: 749-755
4. Bustamante J, Galleano M, Medrano EE, Boveris A (1990) Adriamicyn effects on hydroperoxide metabolism and growth of human breast tumor cells. Breast Cancer Res Treat 17: 145-153
5. Cacace AM, Guadagno SN, Krauss RS, Fabbro D, Weinstein IB (1993) The ipsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene 8: 2095-2104
6. Clurman BE, Sheaff RJ, Thress K, Groudine M, Robertys JM (1996) Turnover of cyclin E by the ubiquitin - proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev 10: 1979-1990
7. Crescimanno M, D'alessandro N, Armata MG, Toulmond S, Tapiero H (1991) Modulation of the antioxidant activities in dox-sensitive and -resistant Friend leukemia cells. Effect of doxorubicin. Anticancer Res 11: 901-903
8. Kip1 on resistance of tumor cells to anticancer agents. Nature Med 2: 1204-1210
9. DeVita VT, Hellman S, Rosenberg SA (2001) Cancer: Principles and Practise of Oncology. Philadelphia: Lippincott Williams and Wilkins
10. Donnellan R, Chetty R (1999) Cyclin E in human cancers. FASEB J 13: 773-780
11. Doroshow JH (1983) Anthracycline antibiotics-stimulated superoxide, hydrogen peroxide and hydroxyl radical production by NADH dehydrogenase. Cancer Res 43: 4543-4551
12. Doroshow J (1986) Prevention of the doxorubicin induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents. Biochem Biophys Res Commun 143: 309-315
13. Eymin B, Haugg M, Droin N, Sordet O, Dimanche-Boitrel M-T, Solary E (1999) p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells. Oncogene 18: 1411-1418
14. Fridovich I (1998) Superoxide radical and superoxide dismutases. Annu Rev Biochem 64: 97-112
15. Friesen C, Fulda S, Debatin K-M (1999) Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells. Cell Death Differ 6: 471-480
16. Galeotti T, Borrello S, Masotti L (1990) Oxy-radical sources, scavenger systems and membrane damage in cancer cells. In Oxygen Radicals: Systemic Events and Disease Processes, Dass DK, Essman WB (eds) pp 129-148. Basel: Karger
17. Hirose K, Longo DL, Oppenhaim JJ, Matsuhima K (1993) Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin 1, tumor necrosis factor, selected anticancer drugs and ionizing radiation. FASEB J 7: 361-368
18. Hochhauser D, Schnieders B, Ercikan-Abali E, Gorlick R, Muise-Helmericks R, Li W-W, Fan J, Banerjee D, Bertino JR (1996) Effects of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line. J Natl Cancer Inst 88: 1269-1275
19. Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W (2000) Superoxide dismutase as a target for the selective killing of cancer cells. Nature 407: 390-395
20. Kartner N, Riordan JR, Ling V (1983) Cell surface P-glycoprotein as associated with multidrug resistance in mammalian cell lines. Science 221: 1285-1288
21. Kasahara K, Fujiwara Y, Sugimoto Y, Nishio K, Tamura T, Matsuda T, Saijio N (1992) Determinants of the response to the DNA topoisomerase II inhibitors doxorubicin and etoposide in human lung cancer cell lines. J Natl Cancer Inst 84: 113-118
22. Kehrer J (1993) Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol 23: 21-48
23. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54: 380-385
24. Koff A, Cross F, Fisher A, Schumacher J, Leguellec K, Philippe M, Roberts JM (1991) Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 66: 1217-1228
25. Nielsen NH, Arnerlov C, Emdin SO, Landberg G (1996) Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br J Cancer 74: 874-880
26. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M (1995) Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 15: 2612-2624
27. Owa T, Yoshino H, Yoshimatsu K, Nagasu T (2001) Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents. Curr Med Chem 8: 1487-1503
28. Palazzotti B, Pani G, Colavitti R, De Leo ME, Bedogni B, Borrello S, Galeotti T (1999) Increased growth capacity of cervical-carcinoma cells overexpressing manganous superoxide dismutase. Int J Cancer 82: 145-150
29. Pani G, Bedogni B, Anzevino R, Colavitti R, Palazzotti B, Borrello S, Galeotti T (2000) Deregulated manganese superoxide dismutase expression and resistance to oxidative injury in p53-deficient cells. Cancer Res 60: 4654-4660
30. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B (1997) A model for p53-induced apoptosis. Nature 389: 300-305
31. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM (1997) Expression of cell-cycle regulators p27 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3: 222-225
32. Sandhu C, Slingerland J (2000) Deregulation of the cell cycle in cancer. Cancer Detect Prev 24: 107-118
33. Sausville EA, Johnson J, Alley M, Zaharevitz D, Senderowicz AM (2000) Inhibition of CDKs as a therapeutic modality. Ann NY Acad Sci 910: 207-221
34. Sgambato A, Ardito R, Faraglia B, Boninsegna A, Wolf FI, Cittadini A (2001) Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. Mut Res 496: 171-180
35. Sgambato A, Doki Y, Schieren I, Weinstein IB (1997) Effects of cyclin E overexpression on cell growth and response to TGF-β depend on cell context and p27Kip1 expression. Cell Growth Diff 8: 393-405
36. Sgambato A, Han EK-H, Zhou P, Schieren I, Weinstein IB (1996) Overexpression of cyclin E in the HC11 mouse mammary cell line is associated with growth inhibition and increased expression of p27Kip1. Cancer Res 56: 1389-1399
37. Sinha BK, Katki AG, Batist G, Cowan KH, Myers CE (1987) Adriamycin-stimulated hydroxyl radical formation in human breast tumor cells. Biochem Pharmacol 36: 793-796
38. Smith ML, Seo YR (2000) Sensitivity of cyclin E-overexpressing cells to cisplatin/taxol combinations. Anticancer Res 20: 2537-2539
39. Spruck CH, Won KA, Reed SI (1999) Deregulated cyclin E induces chromosome instability. Nature 401: 297-300
40. Watanabe N (1998) Endogenous tumor necrosis factor and doxorubicin sensitivity in leukemic patients. Leuk Lymphoma 30: 477-482
41. Yang Q, Sakurai T, Yoshimura G, Takashi Y, Suzuma T, Takami T, Umemura T, Nakamura Y, Nakamura M, Utsunomiya H, Mori I, Kakudo K (2000) Overexpression of p27 protein in human breast cancer correlates with in vitro resistance to doxorubicin and mitomycin C. Anticancer Res 20: 4319-4322
42. Zhu H, Bannenberg GL, Moldeus P, Shertzer HG (1994) Oxidation pathways for the intracellular probe 2′7′-dichlorofluorescein. Arch Toxicol 68: 582-587
43. Zyad A, Benard J, Tursz T, Clarke R, Chouaib S (1994) Resistance to TNF-alfa and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD and TNF gene expression. Cancer Res 54: 825-831